![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Wilbur de Kruijf
Wilbur is General Manager and Chief Technology Officer at Resyca, based in Enschede, The Netherlands. Wilbur has a background in medical product design and human factors engineering. Prior to joining Resyca, Wilbur held a role at Medspray for 15 years, developing the micro spray nozzles and aerosol devices based on that technology. Wilbur has experience working with design consultancy firms, developing a range of medical devices such as wheelchairs, hospital beds, x-ray scanners and drug delivery devices.
Company:Recipharm
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s annual turnover is approximately SEK 11 billion. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden.
